Equity Residential Other Non-Current Liabilities decreased by 5.7% to $306.19M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.6%, from $274.37M to $306.19M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -1.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $341.82M | $350.20M | $353.10M | $303.65M | $292.21M | $287.96M | $306.94M | $283.42M | $294.26M | $231.65M | $272.60M | $274.92M | $292.42M | $294.54M | $310.56M | $274.37M | $290.10M | $298.34M | $324.62M | $306.19M |
| QoQ Change | — | +2.5% | +0.8% | -14.0% | -3.8% | -1.5% | +6.6% | -7.7% | +3.8% | -21.3% | +17.7% | +0.9% | +6.4% | +0.7% | +5.4% | -11.7% | +5.7% | +2.8% | +8.8% | -5.7% |
| YoY Change | — | — | — | — | -14.5% | -17.8% | -13.1% | -6.7% | +0.7% | -19.6% | -11.2% | -3.0% | -0.6% | +27.1% | +13.9% | -0.2% | -0.8% | +1.3% | +4.5% | +11.6% |